Cited 0 times in
Clinical Application of 18F-FDG PET in Nonmelanomatous Skin Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 윤, 준기 | - |
dc.date.accessioned | 2011-11-21T04:12:31Z | - |
dc.date.available | 2011-11-21T04:12:31Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 1975-129X | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/4458 | - |
dc.description.abstract | Nonmelanomatous skin cancer includes basal cell carcinoma, squamous cell carcinoma, merkel cell carcinoma and
dermatofibrosarcoma protuberance. So far, there have been a few reports that 18F-FDG PET was useful in the evaluation of metastasis and therapeutic response in nonmelanomatous skin cancer, however, those are very weak evidences. Therefore, further studies on the usefulness of 18F-FDG PET in nonmelanomatous skin cancer are required. | - |
dc.language.iso | ko | - |
dc.title | Clinical Application of 18F-FDG PET in Nonmelanomatous Skin Cancer | - |
dc.title.alternative | 비흑색종 피부암에서 18F-FDG PET의 임상 이용 | - |
dc.type | Article | - |
dc.subject.keyword | 18F-FDG | - |
dc.subject.keyword | PET | - |
dc.subject.keyword | nonmelanomatous skin cancer | - |
dc.contributor.affiliatedAuthor | 윤, 준기 | - |
dc.type.local | Journal Papers | - |
dc.citation.title | Nuclear medicine and molecular imaging | - |
dc.citation.volume | 42 | - |
dc.citation.number | suppl1 | - |
dc.citation.date | 2008 | - |
dc.citation.startPage | s149 | - |
dc.citation.endPage | s152 | - |
dc.identifier.bibliographicCitation | Nuclear medicine and molecular imaging, 42(suppl1). : s149-s152, 2008 | - |
dc.relation.journalid | J01975129X | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.